Get started
Author

Ping Zhao

Observed names: Ping, Zhao, Zhao Ping
ORCID: 0000-0002-9043-2426
Observed ORCID: 0000-0002-9043-2426
OpenAlex ID: A5021882015
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
2023 · Xiangyu Sun, Ping Zhao, et al. · Cancer Drug Resistance · 85
Mitochondria-targeted cyclometalated rhodium( iii ) complexes: synthesis, characterization and anticancer research
2021 · Yan-Bo Peng, Wei He, et al. · Dalton Transactions · 34
Aptamer-guided upconversion nanoplatform for targeted drug delivery and near-infrared light-triggered photodynamic therapy
2019 · Hui-Chao Lin, Wen-Tian Li, et al. · Journal of Biomaterials Applications · 23
Drug delivery with Mn‐doped MoO 2 for photothermal‐enhanced chemotherapy in fighting cancers
2024 · Ping Zhao, Hai‐Fa Zheng, et al. · Rare Metals · 13
VEGF aptamer/i-motif-grafted multi-functional SPION nanocarrier for chemotherapeutic/phototherapeutic synergistic research
2021 · Bo Fu, Hui-Chao Lin, et al. · Journal of Biomaterials Applications · 5
Combined Photothermal‐Photodynamic Therapy by Ce6 loaded on MoO2 functional nanoplatform
2025 · Songru Liang, Zhongrong Qin, et al. · Next Nanotechnology · 2
Adenosine triphosphate/pH dual-responsive controlled drug release system with high cancer/normal cell selectivity and low side toxicity
2022 · Bo Fu, Hui-Chao Lin, et al. · Journal of Biomaterials Applications · 1
Works count: 8
Citation count: 163
H-index: 5
I10-index: 4
Year
Topic
Type